双能CT虚拟平扫可选择性替代腮腺真平扫
回顾性纳入436例患者446个经手术证实的腮腺病变,评估双能CT虚拟平扫(VUE)与真平扫(TUE)在衰减值和诊断性能上的一致性。VUE与TUE衰减值等效(平均偏差<1 HU),六分类XGBoost诊断性能相当,省略TUE可减少约2.41 mSv辐射剂量。
要点
- VUE与TUE病变衰减值等效,平均偏差<1 HU,可在多期腮腺DECT中考虑省略TUE。
- VUE上背景腺体衰减被高估约14.8–16.7 HU,病变检出和边界清晰度轻度下降。
- 省略TUE估计可降低辐射剂量约2.41 mSv,但需多中心和多厂商验证。
关键影像表现/征象
- VUE与TUE病变衰减平均偏差小于1 HU,84.3%和81.6%的差值在±10 HU以内。
- VUE上背景腺体衰减被高估14.8和16.7 HU。
- VUE上病变检出和边界清晰度轻度降低。
诊断标准与关键数值
- VUE与TUE衰减等效性采用Bland-Altman分析和双侧检验(TOST,等效界值±10 HU),总体及六个组织病理亚组均确认等效(p<0.001)。
- 基于XGBoost的六分类分类器以TUE、VUE_C1或VUE_C2为输入,诊断性能相当。
- 省略TUE的估计辐射剂量降低为2.41±0.37 mSv。
临床应用与阅片要点
- 在多期腮腺DECT中,可考虑用VUE替代TUE以减少辐射剂量,但需注意VUE上背景腺体衰减高估可能影响对腺体背景的判读。
- VUE上病变检出和边界清晰度轻度下降,报告时需结合增强期图像综合评估,避免遗漏或过度诊断。
局限性
- 回顾性单中心设计,结论需更广泛的多中心和多厂商验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: To investigate whether virtual unenhanced (VUE) images can permit selective omission of true unenhanced (TUE) images in multiphasic parotid dual-energy CT (DECT) without compromising attenuation accuracy or diagnostic performance.
MATERIALS AND METHODS: This retrospective study included 446 lesions from 436 patients with surgically confirmed parotid lesions who underwent three-phase DECT (TUE, early and late contrast); VUE was reconstructed from both contrast phases. Agreement between VUE and TUE attenuation was assessed using Bland-Altman analysis and two one-sided tests (TOST; equivalence margin, ±10 HU), both overall and across six histopathological subgroups. Lesion detection and border clarity were compared between VUE and TUE images. XGBoost-based six-category classifiers using TUE, VUE_C1, or VUE_C2 images as input were compared to evaluate diagnostic performance. The radiation dose attributable to the TUE acquisition was estimated from the dose-length product.
RESULTS: VUE reproduced lesion attenuation with a mean bias of less than 1 HU. TOST confirmed equivalence overall and across all six subgroups (p < 0.001), with 84.3% and 81.6% of differences within ± 10 HU. Six-category XGBoost classifiers demonstrated comparable diagnostic performance across TUE, VUE_C1, and VUE_C2 baselines. SHAP feature importance showed strong correlation across models. Background gland attenuation was overestimated on VUE by 14.8 and 16.7 HU, while lesion detection and border clarity were modestly reduced. Omitting the TUE acquisition would provide an estimated dose reduction of 2.41 ± 0.37 mSv.
CONCLUSION: VUE is quantitatively equivalent to TUE for parotid lesion attenuation and largely preserves internally validated diagnostic performance. These findings support reduced-dose DECT protocols with selective omission of TUE in appropriately selected patients, pending broader multicentre and multi-vendor validation.
引用
- Hu H, Luo H, Xi R, et al. Characterization of parotid lesions with dual-energy CT: Can virtual unenhanced images permit selective omission of true unenhanced acquisition? Eur J Radiol. 2026. PMID: 42570577. doi:10.1016/j.ejrad.2026.113126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。